Cargando…

Myeloid Cell Classification and Therapeutic Opportunities Within the Glioblastoma Tumor Microenvironment in the Single Cell-Omics Era

The glioma tumor microenvironment (TME) is complex and heterogeneous, and multiple emerging and current technologies are being utilized for an improved comprehension and understanding of these tumors. Single cell analysis techniques such as single cell genomic and transcriptomic sequencing analysis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Larkin, Collin J., Arrieta, Víctor A., Najem, Hinda, Li, Gongbo, Zhang, Peng, Miska, Jason, Chen, Peiwen, James, Charles David, Sonabend, Adam M., Heimberger, Amy B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244707/ https://www.ncbi.nlm.nih.gov/pubmed/35784281 http://dx.doi.org/10.3389/fimmu.2022.907605

Ejemplares similares

The Eclectic Nature of Glioma-Infiltrating Macrophages and Microglia
por: Arrieta, Víctor A., et al.
Publicado: (2021)

Immune Microenvironment Landscape in CNS Tumors and Role in Responses to Immunotherapy
por: Najem, Hinda, et al.
Publicado: (2021)

The Use of Targeted Cytokines as Cancer Therapeutics in Glioblastoma
por: Sooreshjani, Moloud, et al.
Publicado: (2023)

Next Steps for Immunotherapy in Glioblastoma
por: Cao, Toni Q., et al.
Publicado: (2022)

Myeloid Cells in Glioblastoma Microenvironment
por: De Leo, Alessandra, et al.
Publicado: (2020)

LMD-20. Immune Suppressive Macrophages and Signal Transducer and Activator of Transcription 3 (STAT3) Expression are common in Melanoma Leptomeningeal Disease
por: Najem, Hinda, et al.
Publicado: (2021)

Immunobiology and Cytokine Modulation of the Pediatric Brain Tumor Microenvironment: A Scoping Review
por: Budhiraja, Shreya, et al.
Publicado: (2023)

Intratumoral Delivery of STING Agonist Results in Clinical Responses in Canine Glioblastoma
por: Boudreau, C. Elizabeth, et al.
Publicado: (2021)

Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment
por: Arrieta, Víctor A., et al.
Publicado: (2023)

Topoisomerase II Poisons for Glioblastoma; Existing Challenges and Opportunities to Personalize Therapy
por: Mehta, Amol, et al.
Publicado: (2018)

Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression
por: Najem, Hinda, et al.
Publicado: (2022)

Immune Modulatory Short Noncoding RNAs Targeting the Glioblastoma Microenvironment
por: Wei, Jun, et al.
Publicado: (2021)

T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10
por: Ravi, Vidhya M., et al.
Publicado: (2022)

Biomedical Imaging: Role and Opportunities of Medical Imaging in the “Omics” Era
por: Yen, Tzu-Chen, et al.
Publicado: (2014)

Development of Fish Parasite Vaccines in the OMICs Era: Progress and Opportunities
por: Shivam, Saloni, et al.
Publicado: (2021)

CD11c+CD163+ Cells and Signal Transducer and Activator of Transcription 3 (STAT3) Expression Are Common in Melanoma Leptomeningeal Disease
por: Najem, Hinda, et al.
Publicado: (2021)

Exploring glioblastoma stem cell heterogeneity: Immune microenvironment modulation and therapeutic opportunities
por: Johnson, Amanda L., et al.
Publicado: (2022)

Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy
por: Khan, Fatima, et al.
Publicado: (2023)

IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM
por: Zannikou, Markella, et al.
Publicado: (2023)

Single-Cell Technologies to Decipher the Immune Microenvironment in Myeloid Neoplasms: Perspectives and Opportunities
por: Caprioli, Chiara, et al.
Publicado: (2022)

Targeting the TREM1-positive myeloid microenvironment in glioblastoma
por: Filippova, Natalia, et al.
Publicado: (2022)

Corrigendum: Single-cell technologies to decipher the immune microenvironment in myeloid neoplasms: Perspectives and opportunities
por: Caprioli, Chiara, et al.
Publicado: (2022)

Glioma microenvironment-derived CCL2 recruits regulatory T cells and myeloid-derived suppressor cells
por: Chang, Alan L, et al.
Publicado: (2015)

Erratum to: Targeting the TREM1-positive myeloid microenvironment in glioblastoma
Publicado: (2023)

Functional imaging of immune cell subpopulations in the tumor microenvironment: clinical implications
por: Heimberger, Amy B.
Publicado: (2022)

Challenges and Opportunities for Immunotherapeutic Intervention against Myeloid Immunosuppression in Glioblastoma
por: Exley, Mark A., et al.
Publicado: (2022)

IMMU-10. PILOCYTIC ASTROCYTOMAS SHOW EVIDENCE OF INTRINSIC IMMUNE SURVEILLANCE AND ACTIVATION WITHIN THE TUMOR MICROENVIRONMENT
por: Najem, Hinda, et al.
Publicado: (2023)

Single-Cell Analyses in the Multi-omics Era
Publicado: (2020)

Activation of 4-1BBL(+) B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma
por: Lee-Chang, Catalina, et al.
Publicado: (2020)

Neural Stem Cell Carriers for the Treatment of Glioblastoma Multiforme
por: Miska, Jason, et al.
Publicado: (2015)

Understanding astrocyte differentiation: Clinical relevance, technical challenges, and new opportunities in the omics era
por: Lattke, Michael, et al.
Publicado: (2022)

Malaria in the ‘Omics Era’
por: Pegoraro, Mirko, et al.
Publicado: (2021)

Applications of Single-Cell Omics to Dissect Tumor Microenvironment
por: Guo, Tingting, et al.
Publicado: (2020)

Behaviors of Glioblastoma Cells in in Vitro Microenvironments
por: Diao, Wenwen, et al.
Publicado: (2019)

Modeling Red Blood Cell Metabolism in the Omics Era
por: Key, Alicia, et al.
Publicado: (2023)

A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin
por: Liang, Jiyong, et al.
Publicado: (2023)

Computational approaches for direct cell reprogramming: from the bulk omics era to the single cell era
por: Tran, Andy, et al.
Publicado: (2022)

Cell-directed aptamer therapeutic targeting for cancers including those within the central nervous system
por: Wei, Jun, et al.
Publicado: (2022)

Identification of a unique tumor cell subset employing myeloid transcriptional circuits to create an immunomodulatory microenvironment in glioblastoma
por: Yang, Kaidi, et al.
Publicado: (2022)

Myeloid cells in COVID-19 microenvironment
por: Qin, Guohui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4rh40kh9t44b9dglpd1k4rvj89